GlassScriptPhysician profile
Peter J Morin
NPI 1548207764
$18,960.79
in general payments reported to CMS, 2019-2025
54 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $763 · 2021: $2,596 · 2022: $11K · 2023: $3,933 · 2024: $873 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,953 · Education: $8.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,952.99 |
| Education | $8.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $7,880.87 | 2020-2024 | |
| Abbvie INC. | $1,936.72 | 2021-2025 | |
| Lundbeck LLC | $664.49 | 2020-2024 | Vyepti |
| Emd Serono, INC. | $662.58 | 2021-2024 | Mavenclad, Mavenclad |
| Amneal Pharmaceuticals LLC | $573.82 | 2021-2024 | Rytary |
| Pfizer INC. | $530.47 | 2023-2025 | |
| Kyowa Kirin, INC. | $476.02 | 2020-2023 | Nourianz |
| Neurocrine Biosciences, INC. | $464.14 | 2021-2024 | Ingrezza, Ongentys |
| Harmony Biosciences LLC | $366.70 | 2020-2023 | Wakix |
| Sunovion Pharmaceuticals INC. | $320.01 | 2020-2022 | |
| Sk Life Science, INC. | $287.14 | 2020-2023 | |
| Ge Healthcare | $278.54 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $276.66 | 2021-2023 | |
| Upsher-Smith Laboratories LLC | $275.48 | 2020-2023 | |
| Acadia Pharmaceuticals INC | $247.23 | 2022-2024 | Nuplazid |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Morin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.